Docket
17/352,892,
U.S. Patent Application
(June 21, 2021)
Cite Docket
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 17/352,892 (U.S. Pat. App.)
+ More Snippets
Document
IPR2023-00884, No. 24 Motion PHV - Motion Pro Hac Vice Elliot Choi (P.T.A.B. Jan. 4, 2024)
Cite Document
IPR2023-00884, No. 24 Motion PHV - Motion Pro Hac Vice Elliot Choi (P.T.A.B. Jan. 4, 2024)
+ More Snippets
Document
IPR2023-00884, No. 23 Motion PHV - Motion Pro Hac Vice Zachriah Summers (P.T.A.B. Jan. 4, 2024)
Cite Document
IPR2023-00884, No. 23 Motion PHV - Motion Pro Hac Vice Zachriah Summers (P.T.A.B. Jan. 4, 2024)
+ More Snippets
Document
IPR2023-00884, No. 20 Motion PHV - Motion Pro Hac Vice Daralyn J Durie (P.T.A.B. Dec. 21, 2023)
Cite Document
IPR2023-00884, No. 20 Motion PHV - Motion Pro Hac Vice Daralyn J Durie (P.T.A.B. Dec. 21, 2023)
+ More Snippets
Document
IPR2023-00884, No. 19 Motion PHV - Motion Pro Hac Vice Kira A Davis (P.T.A.B. Dec. 21, 2023)
Cite Document
IPR2023-00884, No. 19 Motion PHV - Motion Pro Hac Vice Kira A Davis (P.T.A.B. Dec. 21, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 124 (N.D.W.Va. Nov. 29, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 124 (N.D.W.Va. Nov. 29, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 102 (N.D.W.Va. Nov. 17, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 102 (N.D.W.Va. Nov. 17, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 90 (N.D.W.Va. Nov. 2, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 90 (N.D.W.Va. Nov. 2, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 88 (N.D.W.Va. Oct. 28, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 88 (N.D.W.Va. Oct. 28, 2022)
+ More Snippets
Document
IPR2023-00884, No. 68 Other other - Petitioners Request for Oral Argument (P.T.A.B. Jul. 8, 2024)
Cite Document
IPR2023-00884, No. 68 Other other - Petitioners Request for Oral Argument (P.T.A.B. Jul. 8, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 85 (N.D.W.Va. Oct. 20, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 85 (N.D.W.Va. Oct. 20, 2022)
+ More Snippets
Document
IPR2023-00884, No. 67 Notice Other - Joint Notice of Stipulation to Modify Due Date 3 (P.T.A.B. Jun. 28, 2024)
Cite Document
IPR2023-00884, No. 67 Notice Other - Joint Notice of Stipulation to Modify Due Date 3 (P.T.A.B. Jun. 28, 2024)
+ More Snippets
Document
IPR2023-00884, No. 66 Other other - Patent Owner’s Objections to Evidence Submitted with Petitioner’s Reply to Patent Owner’s Response (P.T.A.B. Jun. 17, 2024)
Cite Document
IPR2023-00884, No. 66 Other other - Patent Owner’s Objections to Evidence Submitted with Petitioner’s Reply to Patent Owner’s Response (P.T.A.B. Jun. 17, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 78 (N.D.W.Va. Sep. 29, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 78 (N.D.W.Va. Sep. 29, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 77 (N.D.W.Va. Sep. 29, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 77 (N.D.W.Va. Sep. 29, 2022)
+ More Snippets